LISA OLSEN: Open Payments
NPI 1134105364 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 44 payments from 13 companies in 2025. Trend: 2023 $802 · 2024 $855 · 2025 $1,252
Food & beverage: $1,246Education: $5
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $230 |
| E.R. Squibb & Sons, L.L.C. | 8 | $198 |
| ABBVIE INC. | 8 | $169 |
| Otsuka America Pharmaceutical, Inc. | 3 | $159 |
| Janssen Pharmaceuticals, Inc | 3 | $152 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| Alkermes, Inc. | 4 | $82 |
| Lundbeck LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
Products named: REXULTI, COBENFY, VRAYLAR, INVEGA SUSTENNA, Auvelity, INGREZZA, Sunosi, ARISTADA.
Industry payments across UT — which companies pay providers there.
